Announced
Novo Nordisk to acquire Omeros for $2.1bn.
Synopsis
Novo Nordisk, a Danish pharmaceutical company, agreed to acquire to acquire Omeros, a biotechnology research company, for $2.1bn.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2025 Datasite